BioSpace News Archive

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 second quarter financial results on Tuesday, August 4, 2020, after the close of the financial markets

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020, to discuss the Company’s Second Quarter 2020 financial results.

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the closings of an underwritten public offering, the full exercise of the underwriter’s over-allotment option, and a private placement, for total gross proceeds of approximately $6.2 million, prior to deducting underwriting discounts, placement agent fees, and offering expenses.

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of Vapotherm’s proprietary high velocity therapy, which is used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the second quarter of 2020 after the close of trading on Tuesday, August 4, 2020.

LOS ANGELES, CA / ACCESSWIRE / July 21, 2020 / IMAC Holdings, Inc. (NASDAQ:IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that it will be presenting at the LD 500 on Tuesday, September 1 st at 9:00 AM ET/ 6:00 AM PT. CEO, Jeff Ervin will be presenting to a live audience. Register here: https://ld-micro-conference.events.issuerdirect.com/ “We are honor

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June 30, 2020 after the market close on Wednesday, August 5, 2020.

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that Steve Doares, Ph.D., joins Cellectis from Biogen as Senior Vice President of US Manufacturing Manufacturing and Site Head of Raleigh manufacturing plant in NC.

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2020 before market open on Tuesday, August 4, 2020.

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. Eastern Time

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its second quarter 2020 on Thursday, July 30, 2020.